Creese I[au] - Search Results

Year	Number of Results
1972	1
1973	1
1974	2
1975	9
1976	7
1977	6
1978	7
1979	11
1980	11
1981	7
1982	12
1983	10
1984	5
1985	8
1986	14
1987	5
1988	3
1989	3
1990	1
1991	2
1992	3
1993	1
1994	2
1995	1
1996	2
1997	5
1998	1
1999	2
2000	1
2001	1
2022	0

1

Dopamine receptors: subtypes, localization and regulation.

Creese I, Sibley DR, Leff S, Hamblin M. Creese I, et al. Fed Proc. 1981 Feb;40(2):147-52. Fed Proc. 1981. PMID: 7007083 Review.

2

Dopamine receptors in the central nervous system.

Creese I, Morrow AL, Leff SE, Sibley DR, Hamblin MW. Creese I, et al. Int Rev Neurobiol. 1982;23:255-301. doi: 10.1016/s0074-7742(08)60627-3. Int Rev Neurobiol. 1982. PMID: 6749737 Review. No abstract available.

3

Agonist interactions with dopamine receptors: focus on radioligand-binding studies.

Creese I, Sibley DR, Leff SE. Creese I, et al. Fed Proc. 1984 Oct;43(13):2779-84. Fed Proc. 1984. PMID: 6383871 Review.

4

The classification of dopamine receptors: relationship to radioligand binding.

Creese I, Sibley DR, Hamblin MW, Leff SE. Creese I, et al. Annu Rev Neurosci. 1983;6:43-71. doi: 10.1146/annurev.ne.06.030183.000355. Annu Rev Neurosci. 1983. PMID: 6220666 Review. No abstract available.

5

Receptor adaptations to centrally acting drugs.

Creese I, Sibley DR. Creese I, et al. Annu Rev Pharmacol Toxicol. 1981;21:357-91. doi: 10.1146/annurev.pa.21.040181.002041. Annu Rev Pharmacol Toxicol. 1981. PMID: 6263174 Review. No abstract available.

6

Neurochemistry and neuropharmacology.

Friedhoff AJ, Pickar D, Axelrod J, Creese I, Davis KL, Gallagher DW, Greengard P, Housman D, Maas JW, Richelson E, et al. Friedhoff AJ, et al. Among authors: creese i. Schizophr Bull. 1988;14(3):399-412. doi: 10.1093/schbul/14.3.399. Schizophr Bull. 1988. PMID: 2905525 No abstract available.

7

Chronic neuroleptic treatment and dopamine receptor regulation.

Creese I, Snyder SH. Creese I, et al. Adv Biochem Psychopharmacol. 1980;24:89-94. Adv Biochem Psychopharmacol. 1980. PMID: 6105809 Review. No abstract available.

8

Butyrophenone influences on the opiate receptor.

Creese I, Feinberg AP, Snyder SH. Creese I, et al. Eur J Pharmacol. 1976 Mar;36(1):231-5. doi: 10.1016/0014-2999(76)90277-6. Eur J Pharmacol. 1976. PMID: 1261596

9

Dopamine receptor subtype imbalance in schizophrenia.

Hess EJ, Bracha HS, Kleinman JE, Creese I. Hess EJ, et al. Among authors: creese i. Life Sci. 1987 Apr 13;40(15):1487-97. doi: 10.1016/0024-3205(87)90381-x. Life Sci. 1987. PMID: 2951573

10

Dopamine receptors and average clinical doses.

Creese I, Burt DR, Snyder SH. Creese I, et al. Science. 1976 Oct 29;194(4264):546. doi: 10.1126/science.194.4264.546. Science. 1976. PMID: 17783671 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results